Home | All results_reference

[RDF data]
Results Reference #1067

Resource URI: http://static.linkedct.org/resource/results_reference/1067
linkedct:citation Litzow MR, Goloubeva O, Rowe J, et al.: A randomized phase II trial of gemtuzumab ozogamicin vs. liposomal daunorubicin vs. cyclophosphamide plus topotecan, each combined with intermediate dose Ara-C for the treatment of patients with relapsed or refractory acute myelogenous leukemia . [Abstract] Proceedings of the American Society of Clinical Oncology 22: A-2359, 2003.
rdfs:label Results Reference #1067
is linkedct:results_reference of <http://static.linkedct.org/resource/trials/NCT00005962>
linkedct:results_reference_id 1067 (xsd:int)
rdf:type linkedct:results_reference